Stocktoria

BillionToOne, Inc. BLLN

Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2025-11-06
Chart by TradingView
7/9
Piotroski F — financial health
7.37
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Valuation · market cap as of 2026-06-29

Market cap$5.4B
P / E729.2×
P / S17.8×
P / B11.3×
P / FCF345.9×

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024
Financials
Revenue$305.1M$152.6M
Gross profit$208.5M$80.9M
Operating income$16.0M-$47.1M
Net income$7.5M-$41.6M
Operating cash flow$24.6M-$41.4M
Free cash flow$15.7M-$46.8M
Total assets$632.7M$302.1M
Total liabilities$152.5M$134.3M
Shareholders' equity$480.1M-$251.7M
Ratios
Gross margin68.3%53.0%
Operating margin5.3%-30.9%
Net margin2.4%-27.2%
FCF margin5.2%-30.7%
Return on assets1.2%-13.8%
Return on equity1.6%16.5%
Debt / equity0.12×-0.20×
Current ratio11.698.03
Revenue growth100.0%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC51,254$4.0M
SOROS FUND MANAGEMENT LLC14,500$1.1M

Why these scores methodology →

Piotroski F-score: 7/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 7.37 (safe)

  • Working capital / assets 0.81
  • Retained earnings / assets -0.434
  • EBIT / assets 0.025
  • Equity / liabilities 3.147

Sector peers

GOOG · MSFT · META · BABA · DIS · HCA · all Services →

Source: SEC EDGAR filings · CIK 0002070849 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.